Blood protein may reveal hidden heart risks in scleroderma patients
NCT ID NCT07209644
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 23 times
Summary
This study looks at whether a substance in the blood called catestatin can help doctors understand how active systemic sclerosis (a rare autoimmune disease) is, especially when it affects the heart and small blood vessels. Researchers will compare catestatin levels in 70 people with the disease and healthy volunteers. The goal is to see if catestatin could be used as a simple blood test to monitor disease severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.